M&A Buzz In Korea: CJ HealthCare On the Block

CJ Group plans to sell its healthcare affiliate, in what could potentially emerge as the first major M&A deal involving a South Korean pharma firm in recent years. Although the company has not ruled out the option of an initial public offering as an alternative, the sale plan possibly reflects the changing dynamics in the Korean pharma industry.

Incheon_South Korea_1200x675

Leading South Korean food company CJ CheilJedang has hired Morgan Stanley to manage the sale of its wholly-owned subsidiary CJ HealthCare Corp., a mid-size pharma, in what could potentially signal the first major M&A activity in the domestic pharma industry in recent years.

"It is too early to say anything else. Details such as sale method or timing haven't been determined," said

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip